Strattera - Improve Impulse Control With Strattera
December 2nd, 2008

"A Physicians Weight-Loss Secret. Drug-Free Weight-loss Prescription - No-Starving. No Calorie Counting. Effective, Safe. 14 Years Proven Results."

Atomoxetine, marketed under the brand name Strattera, is a neither selective nor epinephrine reuptake inhibitor. It is the first non-stimulant drug for use in the treatment of attention-deficit hyperactivity disorder (ADHD). It is approved for use in children, adolescents, and adults.

Strattera Information

The mechanism by which Strattera works to treat the Attention-Deficit/Hyperactivity Disorder is currently unknown, but is thought to be related to selective inhibition of the pre-synaptic norepinephrine transporter. This drug affects chemicals in the nerves and brain that are responsible for hyperactivity and impulse control.

Strattera was originally intended to be a new antidepressant drug but since norepinephrine is believed to play a role in ADHD, the medicine was approved to treat this disease.

Do not use atomoxetine if you have used within the past two weeks an MAO inhibitor such as:

- tranylcypromine (Parnate)
- selegiline (Eldepryl, Emsam)
- isocarboxazid (Marplan)
- rasagiline (Azilect)
- phenelzine (Nardil)

Also avoid Strattera if you have glaucoma, coronary artery disease, high or low blood pressure, a personal or family history of mental illness, psychotic disorder, bipolar illness, if you are allergic to atomoxetine, or if you have any heart problems. While taking Strattera you may have unusual behavior, suicidal thoughts, depression, or thoughts of hurting yourself.

Take Strattera exactly as it was prescribed for you, and use it regularly to get the most benefit. This medicine should be taken with a full glass of water, with or without food, usually once a day.

It is recommended to stop taking the drug or talk your doctor immediately if you have any of these serious or less serious side effects:

- fainting or feeling light-headed
- trouble concentrating, seizure, severe headache, blurred vision
- urinating less or not at all
- hallucinations, unusual thoughts
- insomnia
- loss of interest in sex, impotence
- loss of appetite
- increased menstrual cramps

After an experiment that took place in September 2005, Strattera was determined to increase risk of suicidal thoughts among children and adolescents. All pediatric patients that take Strattera should be monitored closely for any unusual changes in behavior, suicidal and clinical worsening especially in the first few months of the drug therapy.

The medication may be harmful to the unborn baby and to a nursing baby (although it is not yet known whether atomoxetine passes into breast milk or not). Also the long-term use of the drug can slow a child's growth.

---

Please use the form below to comment on this page:

Name:
Email Address:	(kept private)
Comments:
Let me know if my message is replied to:	yes
Please enter the digits 513 in the box. This keeps away spam robots:

PHP Warning: Unknown(): Unable to load dynamic library 'C:\Program Files\HSphere\3rdparty\PHP\PHP5\ext\php_curl.dll' - The specified module could not be found. in Unknown on line 0 PHP Warning: Unknown(): Unable to load dynamic library 'C:\Program Files\HSphere\3rdparty\PHP\PHP5\ext\php_gd2.dll' - The specified module could not be found. in Unknown on line 0 PHP Warning: Unknown(): Unable to load dynamic library 'C:\Program Files\HSphere\3rdparty\PHP\PHP5\ext\php_mysql.dll' - The specified module could not be found. in Unknown on line 0